Skip to content

Medical Grand Rounds: Publishing in a Pandemic: How Medical Journals are Responding to COVID-19

In This Article

  • On April 16, 2020, the Department of Medicine at Massachusetts General Hospital held its sixth virtual Grand Rounds presentation related to COVID-19
  • Chana A. Sacks, MD, internist at Mass General and images editor at the New England Journal of Medicine, led a discussion on the role of medical journals in the development of new therapies and approaches to patient care during the COVID-19 pandemic

On April 16, 2020, the Department of Medicine at Massachusetts General Hospital held its sixth virtual Grand Rounds presentation related to COVID-19. Chana A. Sacks, MD, internist at Mass General and images editor at the New England Journal of Medicine, led a discussion on the role of medical journals in the development of new therapies and approaches to patient care during the COVID-19 pandemic. 

The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Mass General. Speakers included Martin Hirsch, MD, senior physician in the Infectious Disease Division at Mass General and editor-in-chief of the Journal of Infectious Diseases, Mary Beth Hamel, MD, MPH, internist at Beth Israel Deaconess Medical Center and executive deputy editor of the New England Journal of Medicine, Paul Sax, MD, clinical director of the HIV Program and Division of Infectious Diseases at Brigham and Women’s Hospital, Howard Bauchner, MD, professor of pediatrics and community health sciences at the Boston University School of Medicine and editor-in-chief of Journal of the American Medical Association

Watch the Video »

View all COVID-19 Updates

Learn about COVID-19 Grand Rounds at Mass General

Related topics

Related

On April 9, 2020, the Department of Medicine held its fifth virtual Grand Rounds presentation related to COVID-19. Keith Flaherty, MD, at Massachusetts General Hospital, and Scott Gottlieb, MD, former FDA commissioner, along with other members of the Greater Boston medical community, presented on advancing experimental therapies to treat COVID-19.

Related

Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.